BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2002
View Archived Issues
New therapeutic approaches for renal cell carcinoma presented at the AUA meeting
Read More
Azole CRF1 antagonists presented by BMS
Read More
5-HT receptor ligands and their use in sleep disorders, etc.
Read More
Boehringer Ingelheim patents dual ligands of 5-HT and D4 receptors
Read More
Novel antiandrogens in the Yamanouchi pipeline
Read More
BMS patent describes DNA topoisomerase I inhibitors
Read More
Endocannabinoid receptor modulators identified by Lilly research team
Read More
Antifungal thiazolidinones discovered at Oxford GlycoSciences
Read More
Early clinical data for DRF-1042 presented at ASCO
Read More
Clinical data on one of Igeneon's cancer vaccine candidates discussed at ASCO meeting
Read More
Potent inhibitor of Jak family protein tyrosine kinases discovered at Merck
Read More
Orally bioavailable peptidomimetic rhinoviral protease inhibitor
Read More
Investigational HIV protease inhibitor submitted for review in Europe by BMS
Read More
Dual inhibition of FPP synthetase and IPP isomerase displayed by a new bisphosphonate
Read More
Phase I results support further development of ABX-EGF for cancer
Read More
LymphoRad targets B-cells and B-cell tumors and exerts antitumor activity in preclinical studies
Read More
ThGRF improves sleep parameters and daytime vigilance in insomnia
Read More
Cathepsin S inhibitors with potential application in MS
Read More
Single-dose palonosetron provides prolonged relief from CINV
Read More
MLN-518 enters phase I in AML
Read More
Second phase II trial for GVAX pancreatic cancer vaccine
Read More
Platelet-derived growth factor evaluated in periodontal disease
Read More
Adenosine Therapeutics receives grant to develop A2A adenosine receptor agonists for sepsis
Read More
Patient enrollment completed in phase II trial of BioBypass in peripheral vascular disease
Read More
Moli-1901 enters phase II development in cystic fibrosis
Read More
Start of phase I trial of NOX-700 in type 2 diabetes
Read More